1-5 of 5
Kay Shigemori
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions

Brief Report
Noriaki Yoshida, Kay Shigemori, Nicholas Donaldson, Christopher Trevisani, Nicolas A. Cordero, Kristen E. Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y. Ng, David M. Weinstock
Journal: Blood
Blood (2020) 135 (17): 1467–1471.
https://doi.org/10.1182/blood.2019001815
Published: 2020
Includes: Supplemental data
Journal Articles

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Noriaki Yoshida, MD PhD, Kay Shigemori, Samuel Y. Ng, MD PhD, Ajit Nirmal, PhD, Nicolas Donaldson, Nicolas Cordero, Kristen E. Stevenson, MS, Xia Bu, Mai Takeuchi, MD PhD, Koichi Ohshima, MD PhD, Akinori Yoda, PhD, David M Weinstock
Journal: Blood
Blood (2019) 134 (Supplement_1): 2760.
https://doi.org/10.1182/blood-2019-122525
Published: 2019
Journal Articles

Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas

Raphael Koch, Amanda L. Christie, Jennifer L. Crombie, Adam C. Palmer, Deborah Plana, Kay Shigemori, Sara N. Morrow, Alexandria Van Scoyk, Wenchao Wu, Elizabeth A. Brem, J. Paul Secrist, Lisa Drew, Alwin G. Schuller, Justin Cidado, Anthony Letai, David M. Weinstock
Journal: Blood
Blood (2019) 133 (6): 566–575.
https://doi.org/10.1182/blood-2018-07-865527
Published: 2019
Includes: Supplemental data
Journal Articles

Circulating Micrornas (miRNA) As a Novel Liquid Biopsy and Therapeutic Platform in MYC and Non-MYC Diffuse Large B-Cell Lymphoma (DLBCL)

Afshin Beheshti, PhD, Charles Vanderburg, PhD, Ravi Dashnamoorthy, PhD, John Tyson McDonald, PhD, Amanda L Christie, BS, Kay Shigemori, Hallie Jester, Hong Zhang, PhD, David M. Weinstock, MD, Andrew M Evens, DO,MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 4005.
https://doi.org/10.1182/blood.V130.Suppl_1.4005.4005
Published: 2017
Journal Articles

In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924

Raphael Koch, MD, Amanda L Christie, BS, Noriaki Yoshida, MD PhD, Samuel Y. Ng, MDPhD, Kay Shigemori, Sara N Morrow, Alexandria Van Scoyk, Steven M. Horwitz, MD, Eric Jacobsen, MD, Solimar Santiago, Jian-Guo Ren, Vincent Guerlavais, PhD, D. Allan Annis, Manuel A. Aivado, MD PhD, David M. Weinstock, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 571.
https://doi.org/10.1182/blood.V130.Suppl_1.571.571
Published: 2017